NEFL and Atrophy: In this study, we hypothesize that a combination of structural measurements of MTL subregions extracted from structural MRI and common plasma biomarkers, such as plasma p-tau181 and NfL, is predictive of imminent longitudinal disease progression measured by atrophy and cognitive decline, providing a more feasible solution.